GC Aesthetics
PrivateLast Round
VC Round
Dec 1, 2021
Total Funding Raised
$93.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GC Aesthetics operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a VC Round in December 2021.
GC Aesthetics is a medical technology company that develops, manufactures, and markets a comprehensive range of proprietary aesthetic and reconstructive products, primarily silicone breast implants.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GC Aesthetics Comparables
Compare GC Aesthetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Establishment Labs Holdings Inc. | 83% | |
| POLYTECH Health & Aesthetics | 83% | |
| Silimed | 82% |
For institutional investors. Book with your work email.
GC Aesthetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 1, 2021 | ||||
| VC Round | Oct 29, 2018 | ||||
| Series D | Jul 12, 2016 | ||||
| VC Round | Feb 20, 2014 | ||||
| Series B | Nov 30, 2011 | ||||
Private Equity | Oct 11, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GC Aesthetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Barrys Tea Holdings Unlimited Company | VC Round, Series D |
| Hayfin Capital Management | VC Round |
| Oyster Capital Partners | VC Round |
| OrbiMed | VC Round |
| Oyster Capital Partners | VC Round, Series D |
| Montreux Equity Partners | VC Round, Series B, Series D, Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 103, representing 35% of headcount.
- Jul 27, 2026
Open roles increased to 101, 34% of headcount.
For institutional investors. Book with your work email.
GC Aesthetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GC Aesthetics's valuation, stock price, and market status.
Is GC Aesthetics a public or private company?
GC Aesthetics is a private company.
What is the current stock price of GC Aesthetics?
GC Aesthetics is a private company, so its shares have no public market price. Caplight tracks GC Aesthetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GC Aesthetics worth (valuation)?
Valuation information for GC Aesthetics is not publicly available.
Can I buy GC Aesthetics stock?
GC Aesthetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GC Aesthetics's last funding round?
GC Aesthetics's most recent funding round was VC Round on December 1, 2021.
Who are the main investors in GC Aesthetics?
Key investors in GC Aesthetics include Hayfin Capital Management, OrbiMed, Montreux Equity Partners.
Will GC Aesthetics IPO soon?
No public IPO plans have been announced for GC Aesthetics.
How can I track GC Aesthetics secondary market activity?
Caplight tracks bids, offers, and trades in GC Aesthetics's shares on secondary markets.